Heart Disease
Genetic variant that causes vegetables to taste bitter makes heart-healthy diet challenging for some
Retinal vein occlusion linked to high cholesterol
Heart disease increases risk for severe skin reactions to allopurinol
Polypill strategy effective in US socioeconomically disadvantaged population
Top stories in cardiology: ESC Congress presentations that may impact clinical practice, evolocumab effective for high-risk acute coronary syndrome
Among the top stories in cardiology last week were a preview of presentations from the European Society of Cardiology Congress that could affect clinical practice, and a randomized clinical trial presented at the ESC Congress that found evolocumab was well-tolerated and substantially reduced LDL levels when combined with statin therapy.
Heart disease deaths declining, but not as fast as before
Evinacumab reduces LDL by 49% on top of other therapies in HoFH
VIDEO: Sex differences, barriers persist for women with heart disease
SAN ANTONIO — In this video exclusive, Martha Gulati, MD, MS, FACC, FAHA, division chief of cardiology at the University of Arizona College of Medicine – Phoenix, physician executive director for Banner University Medicine Heart Institute and editor in chief of ACC’s CardioSmart, discusses the importance of considering sex-specific risk factors for CVD.
Biologic therapy for psoriasis reduces coronary inflammation
Part of the Healio Network
Ventricular Fibrillation ECG Review
Ventricular fibrillation is often a fatal arrhythmia. It occurs when the ventricular rate exceeds 400.